Naturally occurring molecule shows potential to treat patients with Parkinson’s

https://www.youtube.com/watch?v=4x2bVLw9VgU

According to the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) published in 2019, neurodegenerative diseases, which affect the structure and function of the central nervous system (CNS), are the largest cause of disability globally. Parkinson’s disease, the most common of these diseases next to Alzheimer’s, is a progressive movement disorder that remains without a cure.

Continue reading

People with mild symptoms can develop immunity against coronavirus, says research

French researchers have found that even mild cases of the Wuhan coronavirus (COVID-19) can produce antibodies in almost all patients. In addition, they reveal that the patient’s defenses against the virus increase as he starts recovery.

Continue reading